Session Details

Speakers, titles, times, and locations of ASGCT presentations

Detailed Program

11: Efficacy and Integration of a Non-Viral ABCA4 Transposon in Treating Stargardt Disease: Evidence from Mice and Primate Studies

Disclosures:   M.E. LeBlanc: 1; Commercial Interest i.e. Company X; SalioGen Therapeutics. 1; What was received? i.e. Honorarium; Salary, Equity. 1; For what role? i.e. Speaker; Employee.

Related Abstract

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.